Buscar
Congreso SOLACI
Home Tags Thrombosis

Tag: thrombosis

apixaban en fibrilacion auricular tavi

Apixaban and Valve Thrombosis after TAVR

solaci - 0
Dietas bajas en carbohidratos y progresión de la calcificación coronaria

CRUNCH Registry: An Option for Underexpanded Stents

solaci - 0
terapia antitrombótica triple

Are Antithrombotics Necessary in Outpatients after COVID-19?

solaci - 0

Thrombotic and Bleeding Risk after TAVR: Quick Tips to Stay Up...

solaci - 0
Síntomas persistentes post COVID-19: mucho más frecuentes de lo que creíamos

Heparin Anticoagulation in Critically Ill COVID-19 Patients: Results that Differ from...

solaci - 0
Síntomas persistentes post COVID-19: mucho más frecuentes de lo que creíamos

Surviving Covid-19 with Good Old Heparin?

solaci - 0
Recomendaciones de la ACC con el nuevo coronavirus

Anticoagulation with Heparin in Non-Critical COVID-19

solaci - 0
Recomendaciones de la ACC con el nuevo coronavirus

Diagnosis and Treatment of Vaccine-Induced Thrombosis

solaci - 0
Es posible esterilizar las máscaras N95 y los barbijos quirúrgicos

Thrombocytopenia and Thrombosis May Be Linked to AstraZeneca Vaccine, Analysis Reports

solaci - 0
Historia natural de la infección asintomática por COVID-19

Major Cause of Myocardial Injury by COVID-19

solaci - 0
1234Page 1 of 4

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad